KYODO NEWS IMAGELINK

報道写真の購入なら共同通信イメージズ

  • 新型コロナウイルス
  • 新型肺炎
  • ジェヒョン

「逆転写ポリメラーゼ連鎖反応」の写真・映像

絞り込み
  • 提供元
  • 日付
  • 種類
  • 向き
  • カテゴリ
並び順
  • 新しい順
102
( 1 100 件を表示)
  • 1
  • 2
102
( 1 100 件を表示)
絞り込み
並び順
  • 新しい順
  • 2021年10月11日
    Prayuth makes a live-televised speech in Bangkok, Thailand in Bangkok, Thailand - 11 Oct 2021

    October 11, 2021, Bangkok, Thailand: The television grab shows Thailand‘s Prime Minister Prayuth Chan O-Cha making a live-televised speech..The prime minister said on Monday that the visitors are required to carry RT-PCR (Reverse transcription polymerase chain reaction) test result document before entering and leaving the country. The government aims to allow more countries to travel to Thailand by December, while the next phase is expected to be on January 1, 2022. Meanwhile, alcohol consumption in restaurants and the entertainment venues reopening are to be considered for approval on December 1. (Credit Image: © Chaiwat Subprasom/SOPA Images via ZUMA Press Wire)、クレジット:©Chaiwat Subprasom/SOPA Images via ZUMA Press Wire/共同通信イメージズ

    商品コード: 2021101205090

  • 2021年10月11日
    Prayuth makes a live-televised speech in Bangkok, Thailand in Bangkok, Thailand - 11 Oct 2021

    October 11, 2021, Bangkok, Thailand: A woman watching the television grab shows Thailand‘s Prime Minister Prayuth Chan O-Cha making a live-televised speech..The prime minister said on Monday that the visitors are required to carry RT-PCR (Reverse transcription polymerase chain reaction) test result document before entering and leaving the country. The government aims to allow more countries to travel to Thailand by December, while the next phase is expected to be on January 1, 2022. Meanwhile, alcohol consumption in restaurants and the entertainment venues reopening are to be considered for approval on December 1. (Credit Image: © Chaiwat Subprasom/SOPA Images via ZUMA Press Wire)、クレジット:©Chaiwat Subprasom/SOPA Images via ZUMA Press Wire/共同通信イメージズ

    商品コード: 2021101205132

  • 2021年10月11日
    Prayuth makes a live-televised speech in Bangkok, Thailand in Bangkok, Thailand - 11 Oct 2021

    October 11, 2021, Bangkok, Thailand: A woman watching the television grab shows Thailand‘s Prime Minister Prayuth Chan O-Cha making a live-televised speech..The prime minister said on Monday that the visitors are required to carry RT-PCR (Reverse transcription polymerase chain reaction) test result document before entering and leaving the country. The government aims to allow more countries to travel to Thailand by December, while the next phase is expected to be on January 1, 2022. Meanwhile, alcohol consumption in restaurants and the entertainment venues reopening are to be considered for approval on December 1. (Credit Image: © Chaiwat Subprasom/SOPA Images via ZUMA Press Wire)、クレジット:©Chaiwat Subprasom/SOPA Images via ZUMA Press Wire/共同通信イメージズ

    商品コード: 2021101205170

  • 2021年09月29日
    Covid-19 Testing for VIP‘s Security in New Delhi

    September 29, 2021, New Delhi, India: A person who will be attending the prayer meeting on Mahatma Gandhi‘s birth anniversary (October 02) at Rajghat memorial get their mandated RT-PCR (Reverse transcription-polymerase chain reaction) Test conducted at a security camp in view if the President, Prime Minister and other VIP‘s attending the event in New Delhi. (Credit Image: © Sondeep Shankar/Pacific Press via ZUMA Press Wire)、クレジット:©Sondeep Shankar/Pacific Press via ZUMA Press Wire/共同通信イメージズ

    商品コード: 2021093003519

  • 2021年09月29日
    Covid-19 Testing for VIP‘s Security in New Delhi

    September 29, 2021, New Delhi, India: A person who will be attending the prayer meeting on Mahatma Gandhi‘s birth anniversary (October 02) at Rajghat memorial get their mandated RT-PCR (Reverse transcription-polymerase chain reaction) Test conducted at a security camp in view if the President, Prime Minister and other VIP‘s attending the event in New Delhi. (Credit Image: © Sondeep Shankar/Pacific Press via ZUMA Press Wire)、クレジット:©Sondeep Shankar/Pacific Press via ZUMA Press Wire/共同通信イメージズ

    商品コード: 2021093003709

  • 2021年09月29日
    Covid-19 Testing for VIP‘s Security in New Delhi

    September 29, 2021, New Delhi, India: A person who will be attending the prayer meeting on Mahatma Gandhi‘s birth anniversary (October 02) at Rajghat memorial get their mandated RT-PCR (Reverse transcription-polymerase chain reaction) Test conducted at a security camp in view if the President, Prime Minister and other VIP‘s attending the event in New Delhi. (Credit Image: © Sondeep Shankar/Pacific Press via ZUMA Press Wire)、クレジット:©Sondeep Shankar/Pacific Press via ZUMA Press Wire/共同通信イメージズ

    商品コード: 2021093003702

  • 2021年09月29日
    Covid-19 Testing for VIP‘s Security in New Delhi

    September 29, 2021, New Delhi, India: A person who will be attending the prayer meeting on Mahatma Gandhi‘s birth anniversary (October 02) at Rajghat memorial get their mandated RT-PCR (Reverse transcription-polymerase chain reaction) Test conducted at a security camp in view if the President, Prime Minister and other VIP‘s attending the event in New Delhi. (Credit Image: © Sondeep Shankar/Pacific Press via ZUMA Press Wire)、クレジット:©Sondeep Shankar/Pacific Press via ZUMA Press Wire/共同通信イメージズ

    商品コード: 2021093003879

  • 2021年07月08日
    Covid-19 testing in Ghaziabad, India - 08 Jul 2021

    July 8, 2021, Ghaziabad, Uttar Pradesh, India: A health worker collects a swab sample from a man for a Reverse transcription-polymerase chain reaction (RT-PCR) based coronavirus testing at the District hospital in Ghaziabad..India records 442,91 New Covid-19 Cases with 817 Deaths in Last 24 Hours. Prime Minister Narendra Modi appointed Mansukh Mandaviya as a new Union health minister For India. (Credit Image: © Pradeep Gaur/SOPA Images via ZUMA Wire)、クレジット:©Pradeep Gaur/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021070901967

  • 2021年07月08日
    Covid-19 testing in Ghaziabad, India - 08 Jul 2021

    July 8, 2021, Ghaziabad, Uttar Pradesh, India: A health worker collects a nasal swab sample from a man for a Reverse transcription-polymerase chain reaction (RT-PCR) based coronavirus testing at the District hospital in Ghaziabad..India records 442,91 New Covid-19 Cases with 817 Deaths in Last 24 Hours. Prime Minister Narendra Modi appointed Mansukh Mandaviya as a new Union health minister For India. (Credit Image: © Pradeep Gaur/SOPA Images via ZUMA Wire)、クレジット:©Pradeep Gaur/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021070901926

  • 2021年07月08日
    Covid-19 testing in Ghaziabad, India - 08 Jul 2021

    July 8, 2021, Ghaziabad, Uttar Pradesh, India: People wait in a queue for Reverse transcription-polymerase chain reaction (RT-PCR) based coronavirus test at the District hospital in Ghaziabad..India records 442,91 New Covid-19 Cases with 817 Deaths in Last 24 Hours. Prime Minister Narendra Modi appointed Mansukh Mandaviya as a new Union health minister For India. (Credit Image: © Pradeep Gaur/SOPA Images via ZUMA Wire)、クレジット:©Pradeep Gaur/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021070901971

  • 2021年07月08日
    Covid-19 testing in Ghaziabad, India - 08 Jul 2021

    July 8, 2021, Ghaziabad, Uttar Pradesh, India: A health worker collects a nasal swab sample from a man for a Reverse transcription-polymerase chain reaction (RT-PCR) based coronavirus testing at the District hospital in Ghaziabad..India records 442,91 New Covid-19 Cases with 817 Deaths in Last 24 Hours. Prime Minister Narendra Modi appointed Mansukh Mandaviya as a new Union health minister For India. (Credit Image: © Pradeep Gaur/SOPA Images via ZUMA Wire)、クレジット:©Pradeep Gaur/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021070901994

  • 2021年05月25日
    Covid-19 Swab-Test in New Delhi, India - 25 May 2021

    May 25, 2021, New Delhi, India: A healthcare worker collects a swab sample for covid-19 testing RT-PCR (Reverse Transcription Polymerase Chain Reaction) test from a child at New Delhi Railway Station in Delhi..India is the world fastest growing pandemic adding 196,427 confirmed cases of covid-19 infection and 3,511 deaths by the pandemic. India death toll due to the virus now is 307,231. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021052604228

  • 2021年05月25日
    Covid-19 Swab-Test in New Delhi, India - 25 May 2021

    May 25, 2021, New Delhi, India: A healthcare worker collects a swab sample for covid-19 testing RT-PCR (Reverse Transcription Polymerase Chain Reaction) test from a child at New Delhi Railway Station in Delhi..India is the world fastest growing pandemic adding 196,427 confirmed cases of covid-19 infection and 3,511 deaths by the pandemic. India death toll due to the virus now is 307,231. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021052606008

  • 2021年05月25日
    Covid-19 Swab-Test in New Delhi, India - 25 May 2021

    May 25, 2021, New Delhi, India: A healthcare worker collects a swab sample for covid-19 testing RT-PCR (Reverse Transcription Polymerase Chain Reaction) test from a woman at New Delhi Railway Station in Delhi..India is the world fastest growing pandemic adding 196,427 confirmed cases of covid-19 infection and 3,511 deaths by the pandemic. India death toll due to the virus now is 307,231. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021052605978

  • 2021年05月25日
    Covid-19 Swab-Test in New Delhi, India - 25 May 2021

    May 25, 2021, New Delhi, India: A healthcare worker collects a swab sample for covid-19 testing RT-PCR (Reverse Transcription Polymerase Chain Reaction) test from a woman at New Delhi Railway Station in Delhi..India is the world fastest growing pandemic adding 196,427 confirmed cases of covid-19 infection and 3,511 deaths by the pandemic. India death toll due to the virus now is 307,231. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021052605907

  • 2021年05月25日
    Covid-19 Swab-Test in New Delhi, India - 25 May 2021

    May 25, 2021, New Delhi, India: A healthcare worker collects a swab sample for covid-19 testing RT-PCR (Reverse Transcription Polymerase Chain Reaction) test from a woman at New Delhi Railway Station in Delhi..India is the world fastest growing pandemic adding 196,427 confirmed cases of covid-19 infection and 3,511 deaths by the pandemic. India death toll due to the virus now is 307,231. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021052606332

  • 2021年05月25日
    Covid-19 Swab-Test in New Delhi, India - 25 May 2021

    May 25, 2021, New Delhi, India: Samples of swab tests seen after collecting the RT-PCR (Reverse Transcription Polymerase Chain Reaction) test from passengers at New Delhi Railway Station in Delhi..India is the world fastest growing pandemic adding 196,427 confirmed cases of covid-19 infection and 3,511 deaths by the pandemic. India death toll due to the virus now is 307,231. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021052606166

  • 2021年05月25日
    Covid-19 Swab-Test in New Delhi, India - 25 May 2021

    May 25, 2021, New Delhi, India: A healthcare worker collects a swab sample for covid-19 testing RT-PCR (Reverse Transcription Polymerase Chain Reaction) test from a child at New Delhi Railway Station in Delhi..India is the world fastest growing pandemic adding 196,427 confirmed cases of covid-19 infection and 3,511 deaths by the pandemic. India death toll due to the virus now is 307,231. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021052606124

  • 2021年05月25日
    Covid-19 Swab-Test in New Delhi, India - 25 May 2021

    May 25, 2021, New Delhi, India: A healthcare seen holding a test tube after collecting swab sample for RT-PCR (Reverse Transcription Polymerase Chain Reaction) test at New Delhi Railway Station in Delhi..India is the world fastest growing pandemic adding 196,427 confirmed cases of covid-19 infection and 3,511 deaths by the pandemic. India death toll due to the virus now is 307,231. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021052606187

  • 2021年05月25日
    Covid-19 Swab-Test in New Delhi, India - 25 May 2021

    May 25, 2021, New Delhi, India: A healthcare worker collects a swab sample for covid-19 testing RT-PCR (Reverse Transcription Polymerase Chain Reaction) test from a girl at New Delhi Railway Station in Delhi..India is the world fastest growing pandemic adding 196,427 confirmed cases of covid-19 infection and 3,511 deaths by the pandemic. India death toll due to the virus now is 307,231. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021052606348

  • 2021年05月25日
    Covid-19 Swab-Test in New Delhi, India - 25 May 2021

    May 25, 2021, New Delhi, India: Passengers stands in a queue while waiting to give their swab samples for Covid-19 testing through rapid antigen methodology and RT-PCR (Reverse Transcription Polymerase Chain Reaction) test at New Delhi Railway Station in Delhi..India is the world fastest growing pandemic adding 196,427 confirmed cases of covid-19 infection and 3,511 deaths by the pandemic. India death toll due to the virus now is 307,231. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021052606320

  • 2021年04月15日
    Covid19 Test in New Delhi, India - 15 Apr 2021

    April 15, 2021, New Delhi, India: A healthcare worker collects a nasal swab sample from a man for Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test outside the DT City Centre Mall..India registered 200,739 new Covid-19 infection cases in the last 24 hours and 1,038 deaths. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041604477

  • 2021年04月15日
    Covid19 Test in New Delhi, India - 15 Apr 2021

    April 15, 2021, New Delhi, India: A healthcare worker collects a mouth swab sample from a kid for Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test outside the DT City Centre Mall..India registered 200,739 new Covid-19 infection cases in the last 24 hours and 1,038 deaths. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041604557

  • 2021年04月15日
    Covid19 Test in New Delhi, India - 15 Apr 2021

    April 15, 2021, New Delhi, India: A healthcare worker collects a mouth swab sample from a woman for Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test outside the DT City Centre Mall..India registered 200,739 new Covid-19 infection cases in the last 24 hours and 1,038 deaths. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041604380

  • 2021年04月15日
    Covid19 Test in New Delhi, India - 15 Apr 2021

    April 15, 2021, New Delhi, India: A healthcare worker holds a test vial after collecting mouth swab sample for Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test outside the DT City Centre Mall..India registered 200,739 new Covid-19 infection cases in the last 24 hours and 1,038 deaths. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041604491

  • 2021年04月15日
    Covid19 Test in New Delhi, India - 15 Apr 2021

    April 15, 2021, New Delhi, India: A healthcare worker collects a mouth swab sample from a man for Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test outside the DT City Centre Mall..India registered 200,739 new Covid-19 infection cases in the last 24 hours and 1,038 deaths. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041604468

  • 2021年04月15日
    Covid19 Test in New Delhi, India - 15 Apr 2021

    April 15, 2021, New Delhi, India: A woman and her child are seen in a queue as she waits for Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test outside the DT City Centre Mall..India registered 200,739 new Covid-19 infection cases in the last 24 hours and 1,038 deaths. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041604404

  • 2021年04月15日
    Covid19 Test in New Delhi, India - 15 Apr 2021

    April 15, 2021, New Delhi, India: A healthcare worker collects a mouth swab sample from a woman for Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test outside the DT City Centre Mall..India registered 200,739 new Covid-19 infection cases in the last 24 hours and 1,038 deaths. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041604364

  • 2021年04月15日
    Covid19 Test in New Delhi, India - 15 Apr 2021

    April 15, 2021, New Delhi, India: A healthcare worker collects a mouth swab sample from a kid for Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test outside the DT City Centre Mall..India registered 200,739 new Covid-19 infection cases in the last 24 hours and 1,038 deaths. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041604526

  • 2021年04月15日
    Covid19 Test in New Delhi, India - 15 Apr 2021

    April 15, 2021, New Delhi, India: A healthcare worker collects a mouth swab sample from a kid for Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test outside the DT City Centre Mall..India registered 200,739 new Covid-19 infection cases in the last 24 hours and 1,038 deaths. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041604437

  • 2021年04月15日
    Covid19 Test in New Delhi, India - 15 Apr 2021

    April 15, 2021, New Delhi, India: A healthcare worker wearing a personal protective equipment (PPE) holds test vials after collecting mouth swab samples for Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test outside the DT City Centre Mall..India registered 200,739 new Covid-19 infection cases in the last 24 hours and 1,038 deaths. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041604466

  • 2021年04月15日
    Covid19 Test in New Delhi, India - 15 Apr 2021

    April 15, 2021, New Delhi, India: A woman is seen wearing a facemask as a measure against Covid-19 during the Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test outside the DT City Centre Mall..India registered 200,739 new Covid-19 infection cases in the last 24 hours and 1,038 deaths. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041604411

  • 2021年04月15日
    Covid19 Test in New Delhi, India - 15 Apr 2021

    April 15, 2021, New Delhi, India: A healthcare worker collects a mouth swab sample from a woman for Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test outside the DT City Centre Mall..India registered 200,739 new Covid-19 infection cases in the last 24 hours and 1,038 deaths. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041604595

  • 2021年04月15日
    Covid19 Test in New Delhi, India - 15 Apr 2021

    April 15, 2021, New Delhi, India: A young girl is seen wearing a cartoon character facemask as a measure against Covid-19 during the Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test outside the DT City Centre Mall..India registered 200,739 new Covid-19 infection cases in the last 24 hours and 1,038 deaths. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041604354

  • 2021年04月15日
    Covid19 Test in New Delhi, India - 15 Apr 2021

    April 15, 2021, New Delhi, India: A healthcare worker collects a mouth swab sample from a man for Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test outside the DT City Centre Mall..India registered 200,739 new Covid-19 infection cases in the last 24 hours and 1,038 deaths. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041604452

  • 2021年04月15日
    Covid19 Test in New Delhi, India - 15 Apr 2021

    April 15, 2021, New Delhi, India: A healthcare worker collects a nasal swab sample from a woman for Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test outside the DT City Centre Mall..India registered 200,739 new Covid-19 infection cases in the last 24 hours and 1,038 deaths. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041604782

  • 2021年04月15日
    Covid19 Test in New Delhi, India - 15 Apr 2021

    April 15, 2021, New Delhi, India: A healthcare worker collects a mouth swab sample from a woman for Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test outside the DT City Centre Mall..India registered 200,739 new Covid-19 infection cases in the last 24 hours and 1,038 deaths. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041604594

  • 2021年04月15日
    Covid19 Test in New Delhi, India - 15 Apr 2021

    April 15, 2021, New Delhi, India: An officer asks people to maintain social distance in a queue as they wait for Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test outside the DT City Centre Mall..India registered 200,739 new Covid-19 infection cases in the last 24 hours and 1,038 deaths. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041604628

  • 2021年04月15日
    Covid19 Test in New Delhi, India - 15 Apr 2021

    April 15, 2021, New Delhi, India: A healthcare worker collects a mouth swab sample from a woman for Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test outside the DT City Centre Mall..India registered 200,739 new Covid-19 infection cases in the last 24 hours and 1,038 deaths. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041604589

  • 2021年04月15日
    Covid19 Test in New Delhi, India - 15 Apr 2021

    April 15, 2021, New Delhi, India: A healthcare worker collects a nasal swab sample from a woman for Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test outside the DT City Centre Mall..India registered 200,739 new Covid-19 infection cases in the last 24 hours and 1,038 deaths. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041604430

  • 2021年04月12日
    Covid-19 testing center at a private hospital in Ghaziabad, India - 12 Apr 2021

    April 12, 2021, Ghaziabad, Uttar Pradesh, India: A healthcare worker wearing a personal protective equipment suite (PPE) seen preparing for Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test..The covid-19 testing Centre at Atlanta Mediworld Multispecialty Hospital, today India reported highest single day rise of covid-19 cases with 168912 positive cases. (Credit Image: © Pradeep Gaur/SOPA Images via ZUMA Wire)、クレジット:©Pradeep Gaur/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041303250

  • 2021年04月12日
    Covid-19 testing center at a private hospital in Ghaziabad, India - 12 Apr 2021

    April 12, 2021, Ghaziabad, Uttar Pradesh, India: A healthcare worker wearing a personal protective equipment suite (PPE) collects a swab sample from a woman for Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test..The covid-19 testing Centre at Atlanta Mediworld Multispecialty Hospital, today India reported highest single day rise of covid-19 cases with 168912 positive cases. (Credit Image: © Pradeep Gaur/SOPA Images via ZUMA Wire)、クレジット:©Pradeep Gaur/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041303148

  • 2021年04月12日
    Covid-19 testing center at a private hospital in Ghaziabad, India - 12 Apr 2021

    April 12, 2021, Ghaziabad, Uttar Pradesh, India: A health worker wearing a personal protective equipment suite (PPE) takes a swab sample from a man for a Reverse Transcription Polymerase Chain Reaction (RT-PCR) test..The covid-19 testing Centre at Atlanta Mediworld Multispecialty Hospital, today India reported highest single day rise of covid-19 cases with 168912 positive cases. (Credit Image: © Pradeep Gaur/SOPA Images via ZUMA Wire)、クレジット:©Pradeep Gaur/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041303185

  • 2021年04月12日
    COVID-19 RT-PCR test in New Delhi, India - 12 Apr 2021

    April 12, 2021, New Delhi, India: A healthcare worker wearing a personal protective equipment (PPE) holds a mouth swab sample vial after Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test at the road side testing centre Wazzirpur industrial area in New Delhi..India registered 168,912 new Covid-19 cases, the highest single-day spike and 904 deaths in the last 24 hours. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041308939

  • 2021年04月12日
    COVID-19 RT-PCR test in New Delhi, India - 12 Apr 2021

    April 12, 2021, New Delhi, India: A healthcare worker wearing a personal protective equipment (PPE) places a mouth swab sample vial into a box after Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test at the road side testing centre Wazzirpur industrial area in New Delhi..India registered 168,912 new Covid-19 cases, the highest single-day spike and 904 deaths in the last 24 hours. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041308541

  • 2021年04月12日
    COVID-19 RT-PCR test in New Delhi, India - 12 Apr 2021

    April 12, 2021, New Delhi, India: A healthcare worker wearing a personal protective equipment (PPE) collects a mouth swab sample from a kid for Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test at the road side testing centre Wazzirpur industrial area in New Delhi..India registered 168,912 new Covid-19 cases, the highest single-day spike and 904 deaths in the last 24 hours. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041308859

  • 2021年04月12日
    COVID-19 RT-PCR test in New Delhi, India - 12 Apr 2021

    April 12, 2021, New Delhi, India: A healthcare worker wearing a personal protective equipment (PPE) collects a mouth swab sample from a kid for Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test at the road side testing centre Wazzirpur industrial area in New Delhi..India registered 168,912 new Covid-19 cases, the highest single-day spike and 904 deaths in the last 24 hours. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041308798

  • 2021年04月12日
    COVID-19 RT-PCR test in New Delhi, India - 12 Apr 2021

    April 12, 2021, New Delhi, India: A healthcare worker wearing a personal protective equipment (PPE) holds a mouth swab sample vial after Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test at the road side testing centre Wazzirpur industrial area in New Delhi..India registered 168,912 new Covid-19 cases, the highest single-day spike and 904 deaths in the last 24 hours. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041308313

  • 2021年04月12日
    COVID-19 RT-PCR test in New Delhi, India - 12 Apr 2021

    April 12, 2021, New Delhi, India: A healthcare worker wearing a personal protective equipment (PPE) collects a mouth swab sample from a man for Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test at the road side testing centre Wazzirpur industrial area in New Delhi..India registered 168,912 new Covid-19 cases, the highest single-day spike and 904 deaths in the last 24 hours. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041308953

  • 2021年04月12日
    COVID-19 RT-PCR test in New Delhi, India - 12 Apr 2021

    April 12, 2021, New Delhi, India: A healthcare worker wearing a personal protective equipment (PPE) places a mouth swab sample vial into a box after Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test at the road side testing centre Wazzirpur industrial area in New Delhi..India registered 168,912 new Covid-19 cases, the highest single-day spike and 904 deaths in the last 24 hours. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041308941

  • 2021年04月12日
    COVID-19 RT-PCR test in New Delhi, India - 12 Apr 2021

    April 12, 2021, New Delhi, India: A healthcare worker wearing a personal protective equipment (PPE) collects a mouth swab sample from a man for Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test at the road side testing centre Wazzirpur industrial area in New Delhi..India registered 168,912 new Covid-19 cases, the highest single-day spike and 904 deaths in the last 24 hours. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041305975

  • 2021年04月12日
    COVID-19 RT-PCR test in New Delhi, India - 12 Apr 2021

    April 12, 2021, New Delhi, India: A healthcare worker wearing a personal protective equipment (PPE) places a mouth swab sample vial into a box after Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test at the road side testing centre Wazzirpur industrial area in New Delhi..India registered 168,912 new Covid-19 cases, the highest single-day spike and 904 deaths in the last 24 hours. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041308998

  • 2021年04月12日
    COVID-19 RT-PCR test in New Delhi, India - 12 Apr 2021

    April 12, 2021, New Delhi, India: A healthcare worker wearing a personal protective equipment (PPE) collects a mouth swab sample from a man for Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test at the road side testing centre Wazzirpur industrial area in New Delhi..India registered 168,912 new Covid-19 cases, the highest single-day spike and 904 deaths in the last 24 hours. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041308870

  • 2021年04月12日
    COVID-19 RT-PCR test in New Delhi, India - 12 Apr 2021

    April 12, 2021, New Delhi, India: A healthcare worker wearing a personal protective equipment (PPE) collects a mouth swab sample from a woman for Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test at the road side testing centre Wazzirpur industrial area in New Delhi..India registered 168,912 new Covid-19 cases, the highest single-day spike and 904 deaths in the last 24 hours. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041308982

  • 2021年04月12日
    COVID-19 RT-PCR test in New Delhi, India - 12 Apr 2021

    April 12, 2021, New Delhi, India: A healthcare worker wearing a personal protective equipment (PPE) collects a mouth swab sample from a man for Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test at the road side testing centre Wazzirpur industrial area in New Delhi..India registered 168,912 new Covid-19 cases, the highest single-day spike and 904 deaths in the last 24 hours. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041308210

  • 2021年04月12日
    COVID-19 RT-PCR test in New Delhi, India - 12 Apr 2021

    April 12, 2021, New Delhi, India: A healthcare worker wearing a personal protective equipment (PPE) collects a mouth swab sample from a woman for Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test at the road side testing centre Wazzirpur industrial area in New Delhi..India registered 168,912 new Covid-19 cases, the highest single-day spike and 904 deaths in the last 24 hours. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041308893

  • 2021年04月12日
    COVID-19 RT-PCR test in New Delhi, India - 12 Apr 2021

    April 12, 2021, New Delhi, India: A healthcare worker wearing a personal protective equipment (PPE) collects a mouth swab sample from a woman for Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test at the road side testing centre Wazzirpur industrial area in New Delhi..India registered 168,912 new Covid-19 cases, the highest single-day spike and 904 deaths in the last 24 hours. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041308899

  • 2021年04月12日
    COVID-19 RT-PCR test in New Delhi, India - 12 Apr 2021

    April 12, 2021, New Delhi, India: A healthcare worker wearing a personal protective equipment (PPE) holds a mouth swab sample vial box after a Covid-19 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test at the road side testing centre Wazzirpur industrial area in New Delhi..India registered 168,912 new Covid-19 cases, the highest single-day spike and 904 deaths in the last 24 hours. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021041308928

  • 2021年04月07日
    Road side covid 19 swab collections in New Delhi, India - 07 Apr 2021

    April 7, 2021, New Delhi, India: A man getting his sample collected by a health worker during swab sample collections for Covid-19 real-time reverse transcription polymerase chain reaction (RT-PCR) test at the road side in New Delhi. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021040805038

  • 2021年04月07日
    Road side covid 19 swab collections in New Delhi, India - 07 Apr 2021

    April 7, 2021, New Delhi, India: A man getting his sample collected by a health worker during swab sample collections for Covid-19 real-time reverse transcription polymerase chain reaction (RT-PCR) test at the road side in New Delhi. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021040805066

  • 2021年04月07日
    Road side covid 19 swab collections in New Delhi, India - 07 Apr 2021

    April 7, 2021, New Delhi, India: A woman getting his sample collected by a health worker during swab sample collections for Covid-19 real-time reverse transcription polymerase chain reaction (RT-PCR) test at the road side in New Delhi. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021040805132

  • 2021年04月07日
    Road side covid 19 swab collections in New Delhi, India - 07 Apr 2021

    April 7, 2021, New Delhi, India: A man getting his sample collected by a health worker during swab sample collections for Covid-19 real-time reverse transcription polymerase chain reaction (RT-PCR) test at the road side in New Delhi. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021040805089

  • 2021年04月07日
    Road side covid 19 swab collections in New Delhi, India - 07 Apr 2021

    April 7, 2021, New Delhi, India: A man getting his sample collected by a health worker during swab sample collections for Covid-19 real-time reverse transcription polymerase chain reaction (RT-PCR) test at the road side in New Delhi. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021040803214

  • 2021年04月07日
    Road side covid 19 swab collections in New Delhi, India - 07 Apr 2021

    April 7, 2021, New Delhi, India: A man getting his sample collected by a health worker during swab sample collections for Covid-19 real-time reverse transcription polymerase chain reaction (RT-PCR) test at the road side in New Delhi. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021040805126

  • 2021年04月07日
    Road side covid 19 swab collections in New Delhi, India - 07 Apr 2021

    April 7, 2021, New Delhi, India: A man getting his sample collected by a health worker during swab sample collections for Covid-19 real-time reverse transcription polymerase chain reaction (RT-PCR) test at the road side in New Delhi. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021040805042

  • 2021年04月07日
    Road side covid 19 swab collections in New Delhi, India - 07 Apr 2021

    April 7, 2021, New Delhi, India: A woman getting his sample collected by a health worker during swab sample collections for Covid-19 real-time reverse transcription polymerase chain reaction (RT-PCR) test at the road side in New Delhi. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021040805072

  • 2021年04月07日
    Road side covid 19 swab collections in New Delhi, India - 07 Apr 2021

    April 7, 2021, New Delhi, India: A man getting his sample collected by a health worker during swab sample collections for Covid-19 real-time reverse transcription polymerase chain reaction (RT-PCR) test at the road side in New Delhi. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021040805128

  • 2021年04月07日
    Road side covid 19 swab collections in New Delhi, India - 07 Apr 2021

    April 7, 2021, New Delhi, India: A man getting his sample collected by a health worker during swab sample collections for Covid-19 real-time reverse transcription polymerase chain reaction (RT-PCR) test at the road side in New Delhi. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021040805138

  • 2021年04月07日
    Road side covid 19 swab collections in New Delhi, India - 07 Apr 2021

    April 7, 2021, New Delhi, India: A woman getting his sample collected by a health worker during swab sample collections for Covid-19 real-time reverse transcription polymerase chain reaction (RT-PCR) test at the road side in New Delhi. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021040805158

  • 2021年04月07日
    Road side covid 19 swab collections in New Delhi, India - 07 Apr 2021

    April 7, 2021, New Delhi, India: A health worker holds a sample vial during swab sample collections for Covid-19 real-time reverse transcription polymerase chain reaction (RT-PCR) test at the road side in New Delhi. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021040803257

  • 2021年04月07日
    Road side covid 19 swab collections in New Delhi, India - 07 Apr 2021

    April 7, 2021, New Delhi, India: A tired health worker quenching her thirst during swab sample collections for Covid-19 real-time reverse transcription polymerase chain reaction (RT-PCR) test at the road side in New Delhi. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021040805134

  • 2021年04月07日
    Road side covid 19 swab collections in New Delhi, India - 07 Apr 2021

    April 7, 2021, New Delhi, India: A health worker holds a test tube with samples during swab sample collections for Covid-19 real-time reverse transcription polymerase chain reaction (RT-PCR) test at the road side in New Delhi. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021040805255

  • 2021年04月07日
    Road side covid 19 swab collections in New Delhi, India - 07 Apr 2021

    April 7, 2021, New Delhi, India: A health worker holds a test tube with samples during swab sample collections for Covid-19 real-time reverse transcription polymerase chain reaction (RT-PCR) test at the road side in New Delhi. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021040805154

  • 2021年04月07日
    Road side covid 19 swab collections in New Delhi, India - 07 Apr 2021

    April 7, 2021, New Delhi, India: A senior citizen getting his sample collected by a health worker during swab sample collections for Covid-19 real-time reverse transcription polymerase chain reaction (RT-PCR) test at the road side in New Delhi. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021040805094

  • 2021年04月07日
    Road side covid 19 swab collections in New Delhi, India - 07 Apr 2021

    April 7, 2021, New Delhi, India: A health worker holds a test tube with samples during swab sample collections for Covid-19 real-time reverse transcription polymerase chain reaction (RT-PCR) test at the road side in New Delhi. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021040805041

  • 2021年03月24日
    RAT/RT-PCR Testing in New Delhi, India - 24 Mar 2021

    March 24, 2021, New Delhi, India: A Health worker wearing a personal protective equipment (PPE) takes a swab sample from a passenger for coronavirus Covid-19 rapid antigen test to curb the spread of coronavirus pandemic at New Delhi Railway Station. .In Delhi random testing of Covid-19 Rapid Antigen Test (RAT) and (RT-PCR), is conducted across airports, Railway and Bus station as precautionary measures to prevent and control the surge of Covid19 cases in Delhi in regards to people coming to the city from other states. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021032502062

  • 2021年03月24日
    RAT/RT-PCR Testing in New Delhi, India - 24 Mar 2021

    March 24, 2021, New Delhi, India: A Health worker wearing a personal protective equipment (PPE) takes a swab sample from a passenger for coronavirus Covid-19 rapid antigen test to curb the spread of coronavirus pandemic at New Delhi Railway Station. .In Delhi random testing of Covid-19 Rapid Antigen Test (RAT) and (RT-PCR), is conducted across airports, Railway and Bus station as precautionary measures to prevent and control the surge of Covid19 cases in Delhi in regards to people coming to the city from other states. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021032502531

  • 2021年03月24日
    RAT/RT-PCR Testing in New Delhi, India - 24 Mar 2021

    March 24, 2021, New Delhi, India: A Health worker wearing personal protective equipment (PPE) collects swab sample from a woman for coronavirus Covid-19 rapid antigen test to curb the spread of coronavirus pandemic at New Delhi Railway Station. .In Delhi random testing of Covid-19 Rapid Antigen Test (RAT) and (RT-PCR), is conducted across airports, Railway and Bus station as precautionary measures to prevent and control the surge of Covid19 cases in Delhi in regards to people coming to the city from other states. (Credit Image: © Naveen Sharma/SOPA Images via ZUMA Wire)、クレジット:©Naveen Sharma/SOPA Images via ZUMA Wire/共同通信イメージズ

    商品コード: 2021032502461

  • 2020年07月24日
    DiaPlexQ of SolGent (COVID-19 Test Kit)

    DAEJEON, SOUTH KOREA, JUL 24: An employee at SolGent, one of the leading test kit makers in Korea, walks past in front of the company logo in Daejeon, South Korea on July 24, 2020. “DiaPlexQ,” the novel coronavirus detection kit developed by SolGent, one of the leading test kit makers in Korea and the first Korean company registered for stockpile procurement by the U.S. Federal Emergency Management Agency (FEMA). SolGent‘s DiaPlexQ is a real-time reverse transcription-polymerase chain reaction diagnostic kit that amplifies and tests a specific gene sequence of the COVID-19 virus. It can produce a diagnosis in under two hours. DiaPlexQ has received emergency use authorization from the US Food and Drug Administration.(Photo by Seokyong Lee/Penta Press)、クレジット:Penta Press/共同通信イメージズ

    商品コード: 2020072809074

  • 2020年07月24日
    DiaPlexQ of SolGent (COVID-19 Test Kit)

    DAEJEON, SOUTH KOREA, JUL 24: An employee at SolGent, one of the leading test kit makers in Korea, walks past in front of the company logo in Daejeon, South Korea on July 24, 2020. “DiaPlexQ,” the novel coronavirus detection kit developed by SolGent, one of the leading test kit makers in Korea and the first Korean company registered for stockpile procurement by the U.S. Federal Emergency Management Agency (FEMA). SolGent‘s DiaPlexQ is a real-time reverse transcription-polymerase chain reaction diagnostic kit that amplifies and tests a specific gene sequence of the COVID-19 virus. It can produce a diagnosis in under two hours. DiaPlexQ has received emergency use authorization from the US Food and Drug Administration.(Photo by Seokyong Lee/Penta Press)、クレジット:Penta Press/共同通信イメージズ

    商品コード: 2020072809043

  • 2020年07月24日
    DiaPlexQ of SolGent (COVID-19 Test Kit)

    DAEJEON, SOUTH KOREA, JUL 24: An employee at SolGent, one of the leading test kit makers in Korea, walks past in front of the company logo in Daejeon, South Korea on July 24, 2020. “DiaPlexQ,” the novel coronavirus detection kit developed by SolGent, one of the leading test kit makers in Korea and the first Korean company registered for stockpile procurement by the U.S. Federal Emergency Management Agency (FEMA). SolGent‘s DiaPlexQ is a real-time reverse transcription-polymerase chain reaction diagnostic kit that amplifies and tests a specific gene sequence of the COVID-19 virus. It can produce a diagnosis in under two hours. DiaPlexQ has received emergency use authorization from the US Food and Drug Administration.(Photo by Seokyong Lee/Penta Press)、クレジット:Penta Press/共同通信イメージズ

    商品コード: 2020072809060

  • 2020年07月24日
    DiaPlexQ of SolGent (COVID-19 Test Kit)

    DAEJEON, SOUTH KOREA, JUL 24: An employee at SolGent, one of the leading test kit makers in Korea, walks past in front of the company logo in Daejeon, South Korea on July 24, 2020. “DiaPlexQ,” the novel coronavirus detection kit developed by SolGent, one of the leading test kit makers in Korea and the first Korean company registered for stockpile procurement by the U.S. Federal Emergency Management Agency (FEMA). SolGent‘s DiaPlexQ is a real-time reverse transcription-polymerase chain reaction diagnostic kit that amplifies and tests a specific gene sequence of the COVID-19 virus. It can produce a diagnosis in under two hours. DiaPlexQ has received emergency use authorization from the US Food and Drug Administration.(Photo by Seokyong Lee/Penta Press)、クレジット:Penta Press/共同通信イメージズ

    商品コード: 2020072809029

  • 2020年07月24日
    DiaPlexQ of SolGent (COVID-19 Test Kit)

    DAEJEON, SOUTH KOREA, JUL 24: You Jae-Hyung, CEO of Solgent Co. Ltd, poses after the interview at the company headquarter in Daejeon, South Korea on July 24, 2020. “DiaPlexQ,” the novel coronavirus detection kit developed by SolGent, one of the leading test kit makers in Korea and the first Korean company registered for stockpile procurement by the U.S. Federal Emergency Management Agency (FEMA). SolGent‘s DiaPlexQ is a real-time reverse transcription-polymerase chain reaction diagnostic kit that amplifies and tests a specific gene sequence of the COVID-19 virus. It can produce a diagnosis in under two hours. DiaPlexQ has received emergency use authorization from the US Food and Drug Administration.(Photo by Seokyong Lee/Penta Press)、クレジット:Penta Press/共同通信イメージズ

    商品コード: 2020072809063

  • 2020年07月24日
    DiaPlexQ of SolGent (COVID-19 Test Kit)

    DAEJEON, SOUTH KOREA, JUL 24: You Jae-Hyung, CEO of Solgent Co. Ltd, poses after the interview at the company headquarter in Daejeon, South Korea on July 24, 2020. “DiaPlexQ,” the novel coronavirus detection kit developed by SolGent, one of the leading test kit makers in Korea and the first Korean company registered for stockpile procurement by the U.S. Federal Emergency Management Agency (FEMA). SolGent‘s DiaPlexQ is a real-time reverse transcription-polymerase chain reaction diagnostic kit that amplifies and tests a specific gene sequence of the COVID-19 virus. It can produce a diagnosis in under two hours. DiaPlexQ has received emergency use authorization from the US Food and Drug Administration.(Photo by Seokyong Lee/Penta Press)、クレジット:Penta Press/共同通信イメージズ

    商品コード: 2020072809114

  • 2020年07月24日
    DiaPlexQ of SolGent (COVID-19 Test Kit)

    DAEJEON, SOUTH KOREA, JUL 24: A laboratory worker at SolGent, one of the leading test kit makers in Korea, displays “DiaPlexQ™ Novel Coronavirus Detection Kit” at SolGent’s headquarters in Daejeon, South Korea on July 24, 2020. “DiaPlexQ,” the novel coronavirus detection kit developed by SolGent, one of the leading test kit makers in Korea and the first Korean company registered for stockpile procurement by the U.S. Federal Emergency Management Agency (FEMA). SolGent‘s DiaPlexQ is a real-time reverse transcription-polymerase chain reaction diagnostic kit that amplifies and tests a specific gene sequence of the COVID-19 virus. It can produce a diagnosis in under two hours. DiaPlexQ has received emergency use authorization from the US Food and Drug Administration.(Photo by Seokyong Lee/Penta Press)、クレジット:Penta Press/共同通信イメージズ

    商品コード: 2020072809031

  • 2020年07月24日
    DiaPlexQ of SolGent (COVID-19 Test Kit)

    DAEJEON, SOUTH KOREA, JUL 24: A laboratory worker at SolGent, one of the leading test kit makers in Korea, displays “DiaPlexQ™ Novel Coronavirus Detection Kit” at SolGent’s headquarters in Daejeon, South Korea on July 24, 2020. “DiaPlexQ,” the novel coronavirus detection kit developed by SolGent, one of the leading test kit makers in Korea and the first Korean company registered for stockpile procurement by the U.S. Federal Emergency Management Agency (FEMA). SolGent‘s DiaPlexQ is a real-time reverse transcription-polymerase chain reaction diagnostic kit that amplifies and tests a specific gene sequence of the COVID-19 virus. It can produce a diagnosis in under two hours. DiaPlexQ has received emergency use authorization from the US Food and Drug Administration.(Photo by Seokyong Lee/Penta Press)、クレジット:Penta Press/共同通信イメージズ

    商品コード: 2020072809108

  • 2020年07月24日
    DiaPlexQ of SolGent (COVID-19 Test Kit)

    DAEJEON, SOUTH KOREA, JUL 24: A laboratory worker at SolGent, one of the leading test kit makers in Korea, displays “DiaPlexQ™ Novel Coronavirus Detection Kit” at SolGent’s headquarters in Daejeon, South Korea on July 24, 2020. “DiaPlexQ,” the novel coronavirus detection kit developed by SolGent, one of the leading test kit makers in Korea and the first Korean company registered for stockpile procurement by the U.S. Federal Emergency Management Agency (FEMA). SolGent‘s DiaPlexQ is a real-time reverse transcription-polymerase chain reaction diagnostic kit that amplifies and tests a specific gene sequence of the COVID-19 virus. It can produce a diagnosis in under two hours. DiaPlexQ has received emergency use authorization from the US Food and Drug Administration.(Photo by Seokyong Lee/Penta Press)、クレジット:Penta Press/共同通信イメージズ

    商品コード: 2020072809067

  • 2020年07月24日
    DiaPlexQ of SolGent (COVID-19 Test Kit)

    DAEJEON, SOUTH KOREA, JUL 24: A laboratory worker at SolGent, one of the leading test kit makers in Korea, displays “DiaPlexQ™ Novel Coronavirus Detection Kit” at SolGent’s headquarters in Daejeon, South Korea on July 24, 2020. “DiaPlexQ,” the novel coronavirus detection kit developed by SolGent, one of the leading test kit makers in Korea and the first Korean company registered for stockpile procurement by the U.S. Federal Emergency Management Agency (FEMA). SolGent‘s DiaPlexQ is a real-time reverse transcription-polymerase chain reaction diagnostic kit that amplifies and tests a specific gene sequence of the COVID-19 virus. It can produce a diagnosis in under two hours. DiaPlexQ has received emergency use authorization from the US Food and Drug Administration.(Photo by Seokyong Lee/Penta Press)、クレジット:Penta Press/共同通信イメージズ

    商品コード: 2020072809075

  • 2020年07月24日
    DiaPlexQ of SolGent (COVID-19 Test Kit)

    DAEJEON, SOUTH KOREA, JUL 24: A laboratory worker at SolGent, one of the leading test kit makers in Korea, displays “DiaPlexQ™ Novel Coronavirus Detection Kit” at SolGent’s headquarters in Daejeon, South Korea on July 24, 2020. “DiaPlexQ,” the novel coronavirus detection kit developed by SolGent, one of the leading test kit makers in Korea and the first Korean company registered for stockpile procurement by the U.S. Federal Emergency Management Agency (FEMA). SolGent‘s DiaPlexQ is a real-time reverse transcription-polymerase chain reaction diagnostic kit that amplifies and tests a specific gene sequence of the COVID-19 virus. It can produce a diagnosis in under two hours. DiaPlexQ has received emergency use authorization from the US Food and Drug Administration.(Photo by Seokyong Lee/Penta Press)、クレジット:Penta Press/共同通信イメージズ

    商品コード: 2020072809052

  • 2020年07月24日
    DiaPlexQ of SolGent (COVID-19 Test Kit)

    DAEJEON, SOUTH KOREA, JUL 24: A laboratory worker at SolGent, one of the leading test kit makers in Korea, displays “DiaPlexQ™ Novel Coronavirus Detection Kit” at SolGent’s headquarters in Daejeon, South Korea on July 24, 2020. “DiaPlexQ,” the novel coronavirus detection kit developed by SolGent, one of the leading test kit makers in Korea and the first Korean company registered for stockpile procurement by the U.S. Federal Emergency Management Agency (FEMA). SolGent‘s DiaPlexQ is a real-time reverse transcription-polymerase chain reaction diagnostic kit that amplifies and tests a specific gene sequence of the COVID-19 virus. It can produce a diagnosis in under two hours. DiaPlexQ has received emergency use authorization from the US Food and Drug Administration.(Photo by Seokyong Lee/Penta Press)、クレジット:Penta Press/共同通信イメージズ

    商品コード: 2020072809120

  • 2020年07月24日
    DiaPlexQ of SolGent (COVID-19 Test Kit)

    DAEJEON, SOUTH KOREA, JUL 24: A laboratory worker at SolGent, one of the leading test kit makers in Korea, indicates the positive result of COVID-19 at SolGent’s headquarters in Daejeon, South Korea, on July 24, 2020. “DiaPlexQ,” the novel coronavirus detection kit developed by SolGent, one of the leading test kit makers in Korea and the first Korean company registered for stockpile procurement by the U.S. Federal Emergency Management Agency (FEMA). SolGent‘s DiaPlexQ is a real-time reverse transcription-polymerase chain reaction diagnostic kit that amplifies and tests a specific gene sequence of the COVID-19 virus. It can produce a diagnosis in under two hours. DiaPlexQ has received emergency use authorization from the US Food and Drug Administration.(Photo by Seokyong Lee/Penta Press)、クレジット:Penta Press/共同通信イメージズ

    商品コード: 2020072809049

  • 2020年07月24日
    DiaPlexQ of SolGent (COVID-19 Test Kit)

    DAEJEON, SOUTH KOREA, JUL 24: A laboratory worker at SolGent, one of the leading test kit makers in Korea, works at SolGent’s headquarters in Daejeon, South Korea on July 24, 2020. “DiaPlexQ,” the novel coronavirus detection kit developed by SolGent, one of the leading test kit makers in Korea and the first Korean company registered for stockpile procurement by the U.S. Federal Emergency Management Agency (FEMA). SolGent‘s DiaPlexQ is a real-time reverse transcription-polymerase chain reaction diagnostic kit that amplifies and tests a specific gene sequence of the COVID-19 virus. It can produce a diagnosis in under two hours. DiaPlexQ has received emergency use authorization from the US Food and Drug Administration.(Photo by Seokyong Lee/Penta Press)、クレジット:Penta Press/共同通信イメージズ

    商品コード: 2020072809115

  • 2020年07月24日
    DiaPlexQ of SolGent (COVID-19 Test Kit)

    DAEJEON, SOUTH KOREA, JUL 24: A laboratory worker at SolGent, one of the leading test kit makers in Korea, works at SolGent’s headquarters in Daejeon, South Korea on July 24, 2020. “DiaPlexQ,” the novel coronavirus detection kit developed by SolGent, one of the leading test kit makers in Korea and the first Korean company registered for stockpile procurement by the U.S. Federal Emergency Management Agency (FEMA). SolGent‘s DiaPlexQ is a real-time reverse transcription-polymerase chain reaction diagnostic kit that amplifies and tests a specific gene sequence of the COVID-19 virus. It can produce a diagnosis in under two hours. DiaPlexQ has received emergency use authorization from the US Food and Drug Administration.(Photo by Seokyong Lee/Penta Press)、クレジット:Penta Press/共同通信イメージズ

    商品コード: 2020072809122

  • 2020年07月24日
    DiaPlexQ of SolGent (COVID-19 Test Kit)

    DAEJEON, SOUTH KOREA, JUL 24: A laboratory worker at SolGent, one of the leading test kit makers in Korea, works at SolGent’s headquarters in Daejeon, South Korea on July 24, 2020. “DiaPlexQ,” the novel coronavirus detection kit developed by SolGent, one of the leading test kit makers in Korea and the first Korean company registered for stockpile procurement by the U.S. Federal Emergency Management Agency (FEMA). SolGent‘s DiaPlexQ is a real-time reverse transcription-polymerase chain reaction diagnostic kit that amplifies and tests a specific gene sequence of the COVID-19 virus. It can produce a diagnosis in under two hours. DiaPlexQ has received emergency use authorization from the US Food and Drug Administration.(Photo by Seokyong Lee/Penta Press)、クレジット:Penta Press/共同通信イメージズ

    商品コード: 2020072809116

  • 2020年07月24日
    DiaPlexQ of SolGent (COVID-19 Test Kit)

    DAEJEON, SOUTH KOREA, JUL 24: A laboratory worker at SolGent, one of the leading test kit makers in Korea, displays “DiaPlexQ™ Novel Coronavirus Detection Kit” at SolGent’s headquarters in Daejeon, South Korea on July 24, 2020. “DiaPlexQ,” the novel coronavirus detection kit developed by SolGent, one of the leading test kit makers in Korea and the first Korean company registered for stockpile procurement by the U.S. Federal Emergency Management Agency (FEMA). SolGent‘s DiaPlexQ is a real-time reverse transcription-polymerase chain reaction diagnostic kit that amplifies and tests a specific gene sequence of the COVID-19 virus. It can produce a diagnosis in under two hours. DiaPlexQ has received emergency use authorization from the US Food and Drug Administration.(Photo by Seokyong Lee/Penta Press)、クレジット:Penta Press/共同通信イメージズ

    商品コード: 2020072809123

  • 2020年07月24日
    DiaPlexQ of SolGent (COVID-19 Test Kit)

    DAEJEON, SOUTH KOREA, JUL 24: A laboratory worker at SolGent, one of the leading test kit makers in Korea, displays “DiaPlexQ™ Novel Coronavirus Detection Kit” at SolGent’s headquarters in Daejeon, South Korea on July 24, 2020. “DiaPlexQ,” the novel coronavirus detection kit developed by SolGent, one of the leading test kit makers in Korea and the first Korean company registered for stockpile procurement by the U.S. Federal Emergency Management Agency (FEMA). SolGent‘s DiaPlexQ is a real-time reverse transcription-polymerase chain reaction diagnostic kit that amplifies and tests a specific gene sequence of the COVID-19 virus. It can produce a diagnosis in under two hours. DiaPlexQ has received emergency use authorization from the US Food and Drug Administration.(Photo by Seokyong Lee/Penta Press)、クレジット:Penta Press/共同通信イメージズ

    商品コード: 2020072809082

  • 2020年07月24日
    DiaPlexQ of SolGent (COVID-19 Test Kit)

    DAEJEON, SOUTH KOREA, JUL 24: A laboratory worker at SolGent, one of the leading test kit makers in Korea, works at SolGent’s headquarters in Daejeon, South Korea on July 24, 2020. “DiaPlexQ,” the novel coronavirus detection kit developed by SolGent, one of the leading test kit makers in Korea and the first Korean company registered for stockpile procurement by the U.S. Federal Emergency Management Agency (FEMA). SolGent‘s DiaPlexQ is a real-time reverse transcription-polymerase chain reaction diagnostic kit that amplifies and tests a specific gene sequence of the COVID-19 virus. It can produce a diagnosis in under two hours. DiaPlexQ has received emergency use authorization from the US Food and Drug Administration.(Photo by Seokyong Lee/Penta Press)、クレジット:Penta Press/共同通信イメージズ

    商品コード: 2020072809118

  • 2020年07月24日
    DiaPlexQ of SolGent (COVID-19 Test Kit)

    DAEJEON, SOUTH KOREA, JUL 24: A laboratory worker at SolGent, one of the leading test kit makers in Korea, works at SolGent’s headquarters in Daejeon, South Korea on July 24, 2020. “DiaPlexQ,” the novel coronavirus detection kit developed by SolGent, one of the leading test kit makers in Korea and the first Korean company registered for stockpile procurement by the U.S. Federal Emergency Management Agency (FEMA). SolGent‘s DiaPlexQ is a real-time reverse transcription-polymerase chain reaction diagnostic kit that amplifies and tests a specific gene sequence of the COVID-19 virus. It can produce a diagnosis in under two hours. DiaPlexQ has received emergency use authorization from the US Food and Drug Administration.(Photo by Seokyong Lee/Penta Press)、クレジット:Penta Press/共同通信イメージズ

    商品コード: 2020072809041

  • 2020年07月24日
    DiaPlexQ of SolGent (COVID-19 Test Kit)

    DAEJEON, SOUTH KOREA, JUL 24: A laboratory worker at SolGent, one of the leading test kit makers in Korea, works at SolGent’s headquarters in Daejeon, South Korea on July 24, 2020. “DiaPlexQ,” the novel coronavirus detection kit developed by SolGent, one of the leading test kit makers in Korea and the first Korean company registered for stockpile procurement by the U.S. Federal Emergency Management Agency (FEMA). SolGent‘s DiaPlexQ is a real-time reverse transcription-polymerase chain reaction diagnostic kit that amplifies and tests a specific gene sequence of the COVID-19 virus. It can produce a diagnosis in under two hours. DiaPlexQ has received emergency use authorization from the US Food and Drug Administration.(Photo by Seokyong Lee/Penta Press)、クレジット:Penta Press/共同通信イメージズ

    商品コード: 2020072809051

  • 2020年07月24日
    DiaPlexQ of SolGent (COVID-19 Test Kit)

    DAEJEON, SOUTH KOREA, JUL 24: A laboratory worker at SolGent, one of the leading test kit makers in Korea, works at SolGent’s headquarters in Daejeon, South Korea on July 24, 2020. “DiaPlexQ,” the novel coronavirus detection kit developed by SolGent, one of the leading test kit makers in Korea and the first Korean company registered for stockpile procurement by the U.S. Federal Emergency Management Agency (FEMA). SolGent‘s DiaPlexQ is a real-time reverse transcription-polymerase chain reaction diagnostic kit that amplifies and tests a specific gene sequence of the COVID-19 virus. It can produce a diagnosis in under two hours. DiaPlexQ has received emergency use authorization from the US Food and Drug Administration.(Photo by Seokyong Lee/Penta Press)、クレジット:Penta Press/共同通信イメージズ

    商品コード: 2020072809113

  • 1
  • 2